Open Access

Long-term air pollution exposure and cardio- respiratory mortality: a review

  • Gerard Hoek1Email author,
  • Ranjini M Krishnan2,
  • Rob Beelen1,
  • Annette Peters3,
  • Bart Ostro4,
  • Bert Brunekreef1, 5 and
  • Joel D Kaufman2
Environmental Health201312:43

DOI: 10.1186/1476-069X-12-43

Received: 19 December 2012

Accepted: 2 April 2013

Published: 28 May 2013

Abstract

Current day concentrations of ambient air pollution have been associated with a range of adverse health effects, particularly mortality and morbidity due to cardiovascular and respiratory diseases. In this review, we summarize the evidence from epidemiological studies on long-term exposure to fine and coarse particles, nitrogen dioxide (NO2) and elemental carbon on mortality from all-causes, cardiovascular disease and respiratory disease. We also summarize the findings on potentially susceptible subgroups across studies. We identified studies through a search in the databases Medline and Scopus and previous reviews until January 2013 and performed a meta-analysis if more than five studies were available for the same exposure metric.

There is a significant number of new studies on long-term air pollution exposure, covering a wider geographic area, including Asia. These recent studies support associations found in previous cohort studies on PM2.5. The pooled effect estimate expressed as excess risk per 10 μg/m3 increase in PM2.5 exposure was 6% (95% CI 4, 8%) for all-cause and 11% (95% CI 5, 16%) for cardiovascular mortality. Long-term exposure to PM2.5 was more associated with mortality from cardiovascular disease (particularly ischemic heart disease) than from non-malignant respiratory diseases (pooled estimate 3% (95% CI −6, 13%)). Significant heterogeneity in PM2.5 effect estimates was found across studies, likely related to differences in particle composition, infiltration of particles indoors, population characteristics and methodological differences in exposure assessment and confounder control. All-cause mortality was significantly associated with elemental carbon (pooled estimate per 1 μg/m3 6% (95% CI 5, 7%)) and NO2 (pooled estimate per 10 μg/m3 5% (95% CI 3, 8%)), both markers of combustion sources. There was little evidence for an association between long term coarse particulate matter exposure and mortality, possibly due to the small number of studies and limitations in exposure assessment. Across studies, there was little evidence for a stronger association among women compared to men. In subjects with lower education and obese subjects a larger effect estimate for mortality related to fine PM was found, though the evidence for differences related to education has been weakened in more recent studies.

Keywords

Air pollution Mortality Motorized traffic Cardiovascular Respiratory Particles

Review

Background

There is growing evidence of mortality effects related to long-term exposure (i.e., exposures of a year or more) to ambient air pollution [13]. Cardiovascular effects of short- and long-term exposure to particulate matter air pollution focusing on PM2.5 have recently been comprehensively reviewed [4, 5]. Experimental and epidemiological studies in the recent decade have significantly increased our knowledge of mechanisms that could plausibly explain the associations observed in epidemiological studies between ambient air pollution and mortality [4].

Most studies have reported associations linked to particulate matter, often represented by the mass concentration of particles smaller than 10 μm (PM10) or 2.5 μm (PM2.5). In many urban areas, motorized traffic emissions are an important source of ambient particles and gaseous pollutants such as nitrogen oxides (NO2 and NO). Exposure contrasts related to traffic emissions are usually poorly represented by the concentration of PM10 or PM2.5, because of the high regional background concentration of these particle metrics from other sources [6, 7]. However, there are more specific markers for traffic related air pollution, which include elemental carbon and ultrafine particles number [710]. Janssen and co-workers recently demonstrated that health impact assessments of traffic-related pollutants based upon PM2.5 seriously underestimated the health risks compared to an assessment based upon elemental carbon [7]. There is also growing evidence of health effects related to ultrafine particles [8, 9]. Finally, the effects of coarse particles (the particle fraction between 2.5 and 10 μm) have attracted renewed attention [11]. Emission controls for road traffic have now substantially reduced tailpipe emissions, and therefore non-tailpipe emissions including engine crankcase emissions (combusted lubricating oil), road, tire and brake wear are becoming increasingly important. A recent study in the Netherlands found similar increases of concentrations in major roads compared to urban background for metals related to break and tire wear (Cu, Zn) as for soot and ultrafine particles which are due to tailpipe emissions [10] . In a review of the limited literature, coarse particles were associated with short-term effects on mortality and hospital admissions, but no evidence was found for long-term exposure effects [11]. The number of studies on long-term coarse particle exposure reviewed was small however at the time.

The aim of the current review is to evaluate the epidemiological evidence for cardiovascular and respiratory mortality effects of long-term exposure to fine particulate matter, including a meta-analysis. We focused on epidemiological studies of mortality, as experimental studies and mechanisms of effect have been discussed in detail previously [4]. The American Heart Association review [4] is updated with a significant number of new studies published in 2009 – 2012. We further include more pollutants in the review, specifically NO2, elemental carbon and coarse particles. We evaluated the findings on potentially susceptible subgroups across studies of PM2.5. In addition, we have included the studies on more specific cardiovascular causes of death, especially fatal myocardial infarction and stroke.

Methods

We performed a search in the databases Medline and Scopus with the search terms air pollution, cohort, and mortality until January 2013. We supplemented the search with studies included in the review by Brook and co-worker [4] and by browsing the reference lists of identified papers. In case more than five studies were identified, we performed a meta-analysis. We tested for heterogeneity of cohort-specific effect estimates and obtained combined effects estimates, using random effects methods of DerSimonian and Laird [12]. The I2 statistic was calculated as a measure of the degree of heterogeneity across studies [13]. I2 ranges from 0 to 100% and can be interpreted as the variability of study-specific effect estimates attributable to true between study effects. From some studies multiple papers were available such as the Six Cities study [1416]. In the meta-analysis we used only the most recent paper, which had longer follow-up. We only included studies in the quantitative meta-analysis that directly provided PM2.5 exposure estimates. For NO2 we only included studies which accounted for intra-urban spatial variation using e.g. dispersion models, land use regression models or spatial interpolation. We used STATA version 10 (Stata Corp, College Station, Texas) for meta-analysis. Effect estimates are presented as excess risks expressed per 10 μg/m3 contrast in exposure, except elemental carbon for which risks were expressed per 1 μg/m3.

PM2.5 and all-cause and cardiovascular mortality

Table 1 and Figures 1 and 2 summarize the studies on long-term air pollution exposure and all-cause and cardiovascular mortality using PM2.5 or PM10 as exposure metric [1439]. Most but not all studies report significant associations between PM2.5 and all-cause mortality. Since the publication of the authoritative American Heart Association Scientific Statement, sixteen new cohort studies were published between 2009 and January 2013. These studies were often performed in more selected groups e.g. female teachers [27, 36] or male truck drivers [32]. The geographic range has also been expanded significantly with several new studies from Japan and China now published. Another tendency is the publication of large studies based upon large population samples (e.g. census), with often less information on confounding variables such as individual smoking habits. Large cohort studies have used neighborhood socio-economic status and co-morbidities strongly associated with smoking as proxies for actual smoking data [26, 38]. Effect estimates differed substantially across studies, with most studies showing less than 10% increase in mortality for an increment of 10 μg/m3 PM2.5. The random effects summary estimate for the percent excess risk per 10 μg/m3 PM2.5 for all-cause mortality was 6.2% (95% CI: 4.1 – 8.4%). A formal test of heterogeneity was statistically significant, with an I2 value of 65% indicating moderate heterogeneity. I2 can be interpreted as the variability in effect estimates due to true between study variability and not chance [13]. The random effects summary effect estimate for cardiovascular mortality was 10.6% (95% CI 5.4, 16.0%) per 10 μg/m3. Thus, the overall effect estimates were larger for cardiovascular than for all-cause mortality. This pattern was found in most of the individual studies, with the exceptions being the Dutch cohort study [23], the US trucking industry cohort study [32] and a national cohort study from New Zealand [35]. Significant and large heterogeneity of effects was found across studies, with an I2 statistic of 61%. After excluding the Miller study [22], moderate heterogeneity remained (I2 = 40%). Overall, the new studies have supported an association between PM2.5 and mortality first identified in the US Six City and ACS studies. It is of interest to note that the weight of the ACS study in the combined effect estimate is 12% for all-cause mortality, documenting that the combined estimate does not rely on one or two studies. Furthermore, effect estimates from the three large population cohorts without individual smoking data [26, 34, 38] were not higher than those from the individual cohort studies. An important question is what the explanation is for the observed heterogeneity of effect estimates. Differences in study population, exposure assessment, pollution mixture, study period, outcome assessment, and confounder control could have contributed to these differences.
https://static-content.springer.com/image/art%3A10.1186%2F1476-069X-12-43/MediaObjects/12940_2012_Article_653_Fig1_HTML.jpg
Figure 1

Meta-analysis of the association between PM 2.5 and all-cause mortality (Relative risk per 10 μg/m 3 ). Overall uses random effects.

https://static-content.springer.com/image/art%3A10.1186%2F1476-069X-12-43/MediaObjects/12940_2012_Article_653_Fig2_HTML.jpg
Figure 2

Meta-analysis of the association between PM 2.5 and cardiovascular mortality (Relative Risk per 10 μg/m 3 ). Overall uses random effects.

Table 1

Summary of effect estimates (excess risk per 10 μg/m 3 ) from cohort studies on particulate matter (PM 10 or PM 2.5 ) and mortality from all causes and cardiovascular diseases

Study

Study population

Follow-up period

Pollutant

Conca(μg/m3)

Spatial scaleb

% change in risk (95% CI) in mortality associated with a 10 μg/m3increase PM

References

      

All cause

Cardiovascular c

 

Harvard six cities

8111 adults in six US cities

1976 - 1989

PM2.5

18 (11–30)

City

13(4, 23)

18 (6, 32)

[15]

Harvard six cities

8096 adults in six US cities

1979 -1998

PM2.5

15 (10–22)

City

16 (7, 26)

28 (13,44)

[14]

Harvard six cities

8096 adults in six US cities

1974 - 2009

PM2.5

16 (11–24)

City

14 (7, 22)

26 (14, 40)

[16]

American Cancer Society (ACS) study

552, 800 adults from 51 US cities

1982 - 1989

PM2.5

18 (9–34)

City

26 (8, 47)

NA

[17]

ACS study

500,000 adults from 51 US cities

1982 -1998

PM2.5

18 (4)

City

6 (2, 11)

9 (3, 16)c

[18]

ACS sub-cohort study

22,905 subjects in Los Angeles area

1982 - 2000

PM2.5

(~9 – 27)

Zip code (Int)

17 (5, 30)

26 (1, 60)c

[19]

German cohort

4752 women in Ruhr area

1985 – 2003

PM10

44 (35–53)

Address (near)

12 (−9, 37)

52 (8, 114)

[20]

German cohort

4752 women in Ruhr and surrounding area

1985 - 2008

PM10

44 (35–53)

Address (near)

22 (6, 41)

61 (26, 104)

[21]

Women’s Health Initiative Observational Study

65,893 postmenopausal women from 36 US metropolitan areas

1994-1998

PM2.5

14 (3–28)

Zip code (near)

NA

76 (25,147)

[22]

Netherlands Cohort Study

120, 852 subjects from Netherlands

1987 -1996

PM2.5

28 (23–37)

Address (LUR)

6 (−3, 16)

4 (−10, 21)

[23]

Nurses’ Health Study

66,250 women from the US north eastern metropolitan areas

1992-2002

PM10

22 (4)

Address (LUR)

11 (1,23)

35 (3, 77)

[24]

Nurses’ Health Study

66,250 women from the US north eastern metropolitan areas

1992-2002

PM2.5

14 (6–28)

Address (LUR)

26 (2, 54)

NA

[25]

Medicare national cohort

13.2 million elderly Medicare recipients across the USA

2000 - 2005

PM2.5

13 (4)

Zip code (Mean)

4 (3, 6)d

 

[26]

California teachers study

45,000 female teachers

2002 -2007

PM2.5

18 (7–39)

Address (near)

6 (−4, 16)

19 (5, 36)c

[27]

Swiss national cohort

National census data linked with mortality

2000 - 2005

PM10

19 (>40)e

Address (Disp)

NA

−1 (−3, 0)

[28]

Health professionals follow-up study

17,545 highly educated men in the midwestern and northeastern US

1989 – 2003

PM2.5

18 (3)

Address (LUR)

−14 (−28,2)

3 (−17, 26)

[29]

Vancouver cohort

452,735 Vancouver residents 45–85 yr

1999 – 2002

PM2.5

4 (0 – 10)

Address (LUR)

NA

7 (-14, 32)

[30]

China nat. hypertension survey

70,497 men and women

1991 - 2000

TSP

289 (113–499)

City

0.3 (0, 1)

1 (0, 2)

[31]

US trucking industry cohort

53,814 men in the US trucking industry

1985 -2000

PM2.5

14 (4)

Address (near)

10 (3, 18)

5 (−7, 19)

[32]

Chinese retrospective cohort study

9,941 adults from five districts of Shenyang city

1998 -2009

PM10

154 (78–274)f

District (mean)

53 (50, 56)

55 (51, 60)

[33]

Canadian national cohort

2.1 million nonimmigrant Canadians . > 25 yr

1991 - 2001

PM2.5

9 (2 – 19)

Enumeration area, N = 45710 (satellite)

10 (5, 15)

15 (7, 24)

[34]

New Zealand Census mortality study

1.06 million adults in urban areas from 1996 census

1996 -1999

PM10

8 (0 – 19)

Census tract (Disp)

7 (3, 10)

6 (1, 11)

[35]

California teachers study

101,784 female teachers

1997- 2005

PM2.5

16 (3–28)

Address (Inter)

1 (−5, 9)

7 (−5, 19)

[36]

Nippon data cohort

7,250 adults > 30 yr throughout Japan

1980 - 2004

PM10

<27 - > 43

District (near)

−2 (−8, 4)

−10 (−19, 0)

[37]

Rome longitudinal study

1,265,058 adults from Rome

2001 - 2010

PM2.5

23 (7 – 32)

Address (DISP, 1 km grid)

4 (3, 5)

6 (4, 8)

[38]

a Mean with minimum – maximum in parentheses (μg/m3). One number in parentheses is standard deviation.

b Spatial scale of exposure assignment, in parentheses exposure assignment method. City = average of monitors within the city; Near = nearest monitor concentration; LUR = land use regression; Disp = dispersion modeling; Inter = interpolation.

c Cardio-pulmonary mortality reported if cardiovascular mortality not available.

d Combining the estimates from the three regions of the USA.

e Median and 90th percentile reported.

f Very high pollution levels that changed significantly during follow-up changing the ranking of the five districts.

Studies adjusted for individual smoking except references [26, 28, 30, 34, 38, 56].

Effect modification

Differences in the fraction of susceptible subjects may have contributed to the observed differences. Brook [4] suggested that women might be more susceptible to ambient air pollution. The studies with higher PM effect estimates, particularly the WHI-study have indeed been performed in women only. However, it is problematic to draw conclusions about susceptible subgroups based upon between-study comparisons as multiple factors differ between studies. A comparison of PM effect estimates between men and women within studies does not provide clear evidence that women have a stronger response (Table 2). The findings from the AHSMOG are difficult to interpret, with higher effects in men in the larger earlier study [40] and larger effects in women in the smaller cohort with longer follow-up [41]. The larger effect estimate for BC for men in a Canadian study [30] has to be interpreted with care, because of the lack of data on a variety of important covariates, including individual smoking data, though the authors argue that smoking likely has not confounded the associations with mortality. In the French PAARC study, effect estimates for the evaluated pollutants (TSP, BS and NO2) were similar among men and women [42]. There is also only weak evidence that effect estimates are larger among never-smokers, though in all evaluated studies a (borderline) significant association was found in never-smokers (Table 2). Associations in current smokers were more variable across the studies, consistent with the larger ‘noise’ generated by smoking. In all four studies, PM2.5 effect estimates were higher for those with the lowest education and there was little indication of an association in those with higher education. The absence of an association in the (highly educated) Health professionals study [29] is consistent with this observation. In contrast, in the French PAARC study, effect estimates for Black Smoke were very similar across educational strata, with significant effect also found in those with a university degree [42]. Furthermore the PM2.5 effect estimates (excess risks) in an extended analysis of the ACS differed less than originally reported: 8.2%, 7.2 and 5.5% per 10 μg/m3 for subjects with low, medium and high education respectively [43]. If confirmed in further studies, it is likely that multiple life style related factors may play a role in the stronger effects observed in less-educated subjects. These may include dietary factors such as lower fruit and anti-oxidant intake [23], higher risk of obesity or other pre-existing diseases, higher actual exposures than assumed in the studies, lack of air conditioning and possibly interaction with other risk factors such as poorer housing conditions e.g. moisture.
Table 2

Effect modification of the effect (excess risk per 10 μg/m 3 ) of PM 2.5 on cardiovascular mortality

Subgroup

ACS [[18]]a

NLCS [[23]]

Harvard six city [[43]]

Nurses health [[24]]

WHI [[22]]

AHSMOG [[40]]

AHSMOG [[41]]

Sex

       

Men

5 (0, 11)

3 (−5, 12)b

33 (8, 63)a

NA

NA

4 (−3,11)

−10 (−−24, 5)

Women

6 (0, 12)

7 (0, 14)

20 (−6, 53)

  

−3 (−9, 2)

42 (6, 90)

Smoking status

       

Never

6 (1, 12)

13 (−4, 32)

36 (2, 82)

83 (20, 179)

18 (−1, 40)

NA

NA

Former

5 (0, 11)

−4 (−17, 13)

29 (−3, 72)

22 (−18, 83)

21 (1, 52)

  

Current

4 (−2, 11)

3 (−10, 19)

35 (94, 74)

−12 (−48, 48)

68 (6, 166)

  

Education

       

Low

11 (6, 18)

20 (−10, 70)a

45 (13, 85)

 

40 (11, 75)

NA

NA

Medium

6 (1, 13)

2 (−16, 24)

30 (−2,73)

 

33 (14, 55)

  

High

1 (−3, 6)

−10 (−35, 20)

−3 (−29, 34)

 

11 (−6, 31)

  

Body mass index

       

Non-Obese

NA

NA

NA

8 (−24, 52)

−1 (−10, 29)c

NA

NA

Obese

   

99 (23, 222)

35 (12, 64)c

  

a Read from graph.

b natural-cause mortality.

c for BMI < 22.5, continuous trend observed NA = not available.

In two studies, PM2.5 effect estimates were substantially higher among subjects with high body mass index [22, 24].

It is likely that subject characteristics might explain part of the variability of air pollution effect estimates across studies where subgroup analyses are limited by power to detect differences. Hence, further research is required to study the effects of air pollution on women, smokers, obese participants, and diabetes mellitus with better measurement of the exposures. Gene-environment interactions have been shown for the (short-term) air pollution effects on inflammation markers [44, 45] Inflammation likely plays an important role in the mechanism of cardiovascular events [3, 4]. Gene-environment interactions have not yet been studied in the framework of mortality cohort studies.

Exposure issues

One of the important sources of variability of effect estimates between studies is likely related to exposure definition and misclassification. While the most important environmental predictor to consider is actual individual-level exposure to ambient particles, which presumably drives the health effects, most studies have used outdoor concentrations at sites distant to the participant’s precise location. The use of outdoor exposures leads to exposure misclassification. In the cohort studies, exposure has been characterized by the outdoor concentration at the city level based upon central site monitoring or the nearest monitor, or modeling at the individual address. Table 1 shows that the spatial scale of assessment and exposure assessment method varied significantly across studies, probably contributing to differences in effect estimates. Differences in pollution range across studies (Table 1) may have contributed as well. These exposure estimates do not take into account time activity patterns such as time spent in the home or in traffic and factors affecting infiltration of particles indoors. There is a large literature documenting the importance of air exchange rate on infiltration of particles indoors. Importantly, these factors may differ between homes within a study area and between study areas in different climates. In a study of short-term effects, PM10 effects on hospital admissions were larger in US cities with lower% of air conditioning, related to higher particle infiltration rates [46]. The impact of air conditioning use has not been investigated yet in the framework of cohort studies. In the Multiethnic study of Atherosclerosis Air study, indoor-outdoor measurements have been performed to adjust the exposure estimates [47, 48] and each participant provides time-activity information to weight exposures between time spent indoors and outdoors. Evidence for the importance of time activity patterns was obtained in the US truckers study, showing higher ambient PM2.5 effect estimates in the population excluding long-haul drivers who spend more time away from home [32]. Other factors could however also explain the higher effect estimated after excluding long-haul drivers. In the WHI study, effect estimates tended to be higher for subjects spending more than 30 minutes outdoors [22]. In a validation study in the Netherlands, the contrast of personal soot exposure for adults living on a major road compared to those living at a background location, was larger for those spending more time at home [49]. Because of the reliance on ambient exposure estimates, it is not surprising that some heterogeneity in effect estimates across studies is found.

Differences in particle composition or contributing sources very likely explain some of the heterogeneity in effect estimates, as was observed for short-term mortality and hospital admission studies of PM2.5 and PM10[5053]. For a comprehensive review we refer to the recent evaluation made by the World Health Organization (http://​www.​euro.​who.​int/​en/​what-we-do/​health-topics/​environment-and-health/​air-quality/​publications/​2013/​review-of-evidence-on-health-aspects-of-air-pollution-revihaap). Particle composition effects have not been systematically investigated in cohort studies with the exception of the California teacher’s study [27]. In a recent review it was shown that on a per microgram per m3 basis, mortality effect estimates were about 10 times larger for EC than for PM2.5[7]. Hence, in locations with higher levels of primary combustion particles we could expect higher PM2.5 effects. In the next section, evidence on EC is further discussed.

A further important issue is for which period exposure is characterized. Air pollution data may not be available for the entire follow-up period. As an example in the ACS study, PM2.5 data were available at the start and end of follow-up [18]. When significant (often downward) trends in pollution occur with changing (often decreasing) spatial contrasts in the study, bias may occur in the estimated association between pollution and mortality. The follow-up study from the Harvard Six City study [14] and two studies in potentially at-risk populations [54, 55] suggested that the relevant exposure for cardiovascular effects may be the exposure in the past few years. These authors conclude that it does not take decades to bridge the gap between the short- and long-term exposure effect estimates, consistent with the effect of intervention studies showing reductions in mortality in the year after the intervention [54, 55]. These studies [54, 55] have made use of long-term temporal contrast within cities adjusting for secular trends. PM effect estimates were similar to the previously discussed studies exploiting spatial contrasts.

A further temporal issue in studies that use land use regression models for exposure assessment is that these models often are based upon current measurement campaigns and linked to health outcomes that occurred in the past. Three studies in the Netherlands, Rome (Italy) and Vancouver (Canada) have shown that for periods of about 10 years current LUR models predicted historic spatial contrasts well [5658]. Even when concentrations have decreased over time, spatial contrasts often remain stable. Spatial contrasts may not be stable in areas with rapid economic development as indicated in one of the Chinese cohort studies in which the ranking of study areas changed during follow-up [33, 59]. Even when the ranking of subjects is not changed, the quantitative spatial contrast in a study area may have changed, e.g. because the difference between major roads and background locations has decreased in time. Changed spatial contrasts will affect the estimated slope of the mortality pollution association [18, 56]. Moving of subjects may further complicate the assessment.

An important question to address for the traffic pollution studies is potential confounding by road traffic noise, which has been shown to be related to cardiovascular disease including MI as well. A few studies have attempted to disentangle traffic-related air pollution and noise [6062]. These studies found moderate correlations between air pollution and noise. The three studies differed somewhat in their findings of independent air pollution and noise effects. More work is needed in this area.

Coarse particles and elemental carbon

Table 3 presents studies that have used elemental carbon or coarse PM as the exposure metric. Table 3 illustrates that there is no evidence that long-term exposure to coarse PM is related to mortality. In three of the four cohort studies that reported no significant association with coarse PM, significant associations with PM2.5 were found [18, 25, 63]. However, exposure assessment for coarse particles is more challenging than for PM2.5 because of the influence of local sources, hence central site monitors are likely to have greater errors in representing residential concentrations. It is therefore possible that with more spatially resolved exposure assessment methods such as land use regression models or dispersion models, potential long-term exposure effects will be detected. The California Teacher’s study did not evaluate coarse PM and did not find significant associations between all-cause mortality and elemental concentrations of Si, Fe and Zn, elements abundant in coarse particles, but did report an association between Si and ischemic heart disease [27].
Table 3

Summary of effect estimates (excess risk per 10 μg/m 3 ) from cohort studies on coarse particulate matter and elemental carbon (per 1 μg/m 3 ) and mortality from all causes and cardiovascular diseases

Study name

Study design

Follow-up period

Pollutant

Conca (μg/m3)

Spatial scaleb

% change in risk (95% CI) in mortality

References

      

All causes

Cardiovascular c

 

Coarse PM

        

ACS study

500,000 adults 51 US cities

1982 - 1998

PM2.5–15

19 (6)

City

1 (−2 3)

2 (−2, 5)*

[18]

AHSMOG study

3769 California seventh-day Adventists

1977 – 1992

PM2.5–15

27 (4 – 44)

Address (Inter)

5 (−8, 20)

NA

[63]

Nurses’ Health Study

66,250 women from US north eastern metropolitan areas

1992- 2002

PM2.5–10

8 (0 – 27)

Address (LUR)

3 (−11, 18)

NA

[25]

Health professionals follow-up study

17,545 highly educated men in the midwestern and northeastern US

1989 – 2003

PM2.5–10

10 (3)

Address (LUR)

−10 (−22, 4)

8 (−10, 29)

[29]

EC

        

Netherlands Cohort Study

120, 852 subjects from Netherlands

1987 - 1996

BSe

17 (9–36)

Address (LUR)

5 (0, 11)

4 (−5, 13)

[23]

ACS study (extended)

500,000 adults 51 US cities

1982 – 1998

EC

IQR = 0.31

City

6 (1, 11)

11 (3, 19)

[64]

Worcester MI survivors

3,895 MI patients

1995 - 2005

EC

0.4 (0.1 – 0.9)

Address (LUR)

2 (−7, 11)d

NA

[65]

15 (3, 29)

Vancouver cohort

452,735 Vancouver residents 45–85 yr

1999 – 2002

BC

1.5 (0–5)

Address (LUR)

NA

6 (3, 9)

[30]

PAARC

14,284 adults in 24 French areas

1974 – 1998

BS

44 (18–77)

Address (near)

7 (3, 10)

5 (−2, 12)

[42]

Veteran’s study

70,000 male US veterans

1997 – 2001

EC

0.6 (0.1 – 2.0)

County (mean)

18 (5, 33)

NA

[66]

California teachers study

45,000 female teachers

2002 -2007

EC

1.1 (0.2 – 2.4)

Address (near)

3 (−11,19)

11 (−9, 36)

[27]

Two Scotch cohorts

15, 402 and 7,028 adults from West-central and central Scotland

1972 - 1998 1970 - 1998

BS

19

LUR + temporal

5 (1,9)

7 (0, 13)

[67]

a Mean with minimum – maximum in parentheses (μg/m3). One number in parentheses is standard deviation.

b Spatial scale of exposure assignment, in parentheses exposure assignment method. City = average of monitors within the city; Near = nearest monitor concentration; LUR = land use regression; Disp = dispersion modeling; Inter = interpolation.

c Cardio-pulmonary mortality reported if cardiovascular mortality not available.

d HRs for first two years after MI and after the first two years of survival.

e BC (Black Carbon), BS (Black Smoke) and EC (Elemental carbon) are different markers used to assess soot. Increases consistent with a 1 μg/m3 increase in EC were used [7].

Studies adjusted for individual smoking except references [26, 28, 30, 34, 38, 56].

Consistently, the summary estimate for PM10 was smaller than for PM2.5 with a summary effect estimate per 10 μg/m3 of 3.5% (95% CI 0.4%, 6.6%) with significant heterogeneity (I2 = 69%) of the studies included in Table 1, excluding the because of changing spatial patterns difficult to interpret Chinese retrospective study [33]. The PM10 analysis was added as several studies only report PM10.

Effect estimates for EC were very consistent across studies [23, 27, 30, 42, 6467]. The random effects summary estimate for all-cause mortality per 1 μg/m3 EC was 6.1% (95% CI 4.9%, 7.3%), with highly non-significant heterogeneity of effect estimates (I2 = 0%). Most of the included studies assessed EC exposure at the city-scale [27, 64] which represents variation in city background but does not account for small-scale variation related to proximity to major roads. Many studies have documented significant intra-urban contrasts for EC, related to especially major roads [7]. Most likely EC and NO2 should be considered representatives of the complex mixture of traffic-related air pollution, rather than the only components causally associated with mortality.

There is fairly consistent evidence of associations of mortality with nitrogen dioxide (Table 4). The random effects summary estimate for all-cause mortality per 10 μg/m3 for NO2 was 5.5% (95% CI 3.1%, 8.0%), with significant and large heterogeneity of effect estimates (I2 = 73%). In this analysis, the Chinese study [33] was not included as exposure was assessed at the district level. Inclusion of the essentially null findings of the ACS study-excess risk of 0.3% (95% CI −0.8, 1.3%)- resulted in an only slightly smaller combined estimate of 4.7% (95% CI 2.4, 7.1%). In the ACS study, intra-urban variation was also not accounted for. As traffic-related air pollution varies on a small spatial scale, it is even more critical to assess exposure on a fine spatial scale such as the residential address than for PM2.5.
Table 4

Summary of cohort studies on NO 2 and mortality from all causes and cardiovascular diseases (excess risk per 10 μg/m 3 )

Study name

Study population

Follow-up period

Pollutant

Conca(μg/m3)

Spatial scaleb

% change in risk (95% CI) in mortality per 10 μg/m3

References

      

All causes

Cardiovascular

 

Oslo cohort

16,209 men in Oslo, Norway

1972 – 1998

NOx

11 (1 – 168)

Address (DISP)

8 (6,11)

NA

[68]

Netherlands Cohort Study

120, 852 subjects from Netherlands

1987 -1996

NO2

37 (15–67)

Address (LUR)

8 (0, 16)

7 (−6, 21)

[23]

German cohort

4752 women in Ruhr and surrounding area

1985 – 2003

NO2

39 (20 – 60)

Address (near)

11 (1,21)

36 (14, 63)

[20]

German cohort

4752 women in Ruhr and surrounding area

1985 – 2008

NO2

39 (20 – 60)

Address (near)

11 (4,18)

32 (18, 47)

[21]

PAARC

14,284 adults in 24 French areas

1974 – 1998

NO2

20 (12 – 32)

Address (near)

14 (3, 25)

27 (4, 56)

[42]

China nat. hypertension survey

70,497 men and women

1991 - 2000

NOx

50 (20 – 122)

City

2 (0, 3)

2 (1, 4)

[31]

Vancouver cohort

452,735 Vancouver residents aged 45–85 yr

1999 – 2002

NO2

32 (15 – 58)

Address (LUR)

NA

5 (1, 9)

[30]

DCH

52,061 adults in Copenhagen and Arhus

1993 - 2009

NO2

17 (11 – 60)

Address (DISP)

8 (2, 13)

15 (3,27)

[69]

US trucking industry cohort

53,814 men in the US trucking industry

1985 -2000

NO2

28 (14)

Address (LUR)

5 (3, 7)

4 (0, 8)

[32]

Chinese retrospective cohort study

9,941 adults from five districts of Shenyang city

1998 -2009

NO2

46 (18–78)

District (mean)

145 (134, 158)

146 (131, 163)

[33]

Rome longitudinal study

684,000 adults from Rome

2001 - 2006

NO2

45 (11)

Address (LUR)

4 (3, 5)

NA

[56]

California Teachers study

101,784 female teachers

1997 -2005

NO2

67 (10 – 134)

Address (Inter)

−3 (−9, 4)

−2 (−12, 9)

[36]

Shizuoka elderly cohort

13,444 adults > 65 yr

1999 - 2006

NO2

25 (−19, 75)

Address (LUR)

2 (−4, 8)

15 (3, 28)

[70]

Ontario tax cohort

205, 440 adults in Toronto, Hamilton,Windsor

1982 – 2004

NO2

43 (8), 31 (6), 24 (5)c

Address (LUR)

NA

8 (5, 11)

[71]

Rome longitudinal study

1,265,058 adults from Rome

2001 - 2010

NO2

44 (13–75)

Address (LUR)

3 (2, 3)

3 (2, 4)

[38]

a Mean with minimum – maximum in parentheses (μg/m3). One number in parentheses is standard deviation.

b Spatial scale of exposure assignment, in parentheses exposure assignment method. City = average of monitors within the city; Near = nearest monitor concentration; LUR = land use regression; Disp = dispersion modeling; Inter = interpolation.

c Mean (IQR) per city.

Studies adjusted for individual smoking except references [26, 28, 30, 34, 38, 56].

Specific cardiovascular causes of death

Table 5 shows associations between ambient air pollution and mortality from ischemic heart disease or myocardial infarction (MI), including studies based upon death certificates, more detailed studies using registry data, or ideally cohort studies with epidemiological review of medical records, allowing more precise identification of disease incidence. Several case–control studies based upon M.I. registries or epidemiological studies with clinical review have found associations between NO2 and fatal M.I. but not non-fatal M.I. [7274]. Thus far, the finding of associations for fatal MI only was interpreted as an evidence that air pollution particularly affects the frail, or acts to aggravate a disease progression caused by other factors. On the other hand, it is also possible that the outcomes of ischemic heart diseases are misclassified and combined as composite outcomes, where fatal outcomes are captured more precisely [75]. Although there is increasing evidence that air pollution is associated with markers of early atherosclerosis, it is possible that air pollution will affect the underlying biological processes that predispose to atherothrombosis (which leads to MI and stroke) compared to atherosclerosis [76, 77]. Another explanation is that the type of outcomes affected by pollution are those that have higher case-fatality rates (e.g., arrhythmic sudden death has higher case-fatality rate than overall MI).
Table 5

Summary of the studies on particulate matter and NO2 and mortality from specific cardiovascular diseases (excess risk per 10 μg/m3)

Study name

Pollutant

Conca(μg/m3)

Spatial scaleb

% change in risk (95% CI) in mortality associated with a 10 μg/m3increase

References

    

IHD mortality

M.I mortality

Cerebrovascular mortality

 

ACS study

PM2.5

17 (5)

City

18 (14, 23)

NA

2 (−5, 10)

[39]

Oslo cohort

NOx

11 (1 – 168)

Address (DISP)

8 (3, 12)

NA

4 (−6, 15)

[68]

Women’s Health Initiative Study

PM2.5

14 (3–28)

Zip code 5 (near)

76 (25,147)

NA

NA

[22]

Netherlands Cohort Study

BS

17 (9–36)

Address (LUR)

1 (−17, 22)

NA

39 (−1, 94)

[23]

Nurses’ Health Study

PM10

22 (4)

Address (LUR)

35 (3, 77)

NA

NA

[24]

Nurses’ Health Study

PM2.5

14 (6–28)

Address (LUR)

NA

102 (7, 278)

NA

[25]

California teachers study

PM2.5

18 (7–39)

Address (near)

55 (24, 93)

NA

NA

[27]

Swiss national cohort

PM10

19 (>40)c

Address (Disp)

−1 (−3, 0)

NA

−1 (−2, 0)

[28]

Health professionals follow-up study

PM2.5

18 (3)

Address (LUR)

−2 (−30, 35)

NA

NA

[29]

Canadian national cohort

PM2.5

9 (2 – 19)

Enumeration area, N = 45710 (satellite)

30 (18,43)

NA

4 (−7, 16)

[34]

Californian Teachers study

PM2.5

16 (3–28)

Address (Inter)

20 (2, 41)

NA

16 (−8, 46)

[36]

Shizuoka elderly cohort

NO2

25 (−19, 75)

Address (LUR)

27 (2, 58)

NA

9 (−6, 27)

[70]

Nippon data cohort

PM10

<27 - > 43

District (near)

−8 (−27, 17)

NA

−14 (−26,1)

[37]

DCH

NO2

17 (11 – 60)

Address (Disp)

7 (−9, 26)

NA

6 (−14, 32)

[69]

Ontario Tax cohort

NO2

43 (8), 31 (6), 24 (5)c

Address (LUR)

9 (4, 14)

NA

−4 (−10, 5)

[71]

Rome longitudinal study

PM2.5

23 (7 – 32)

Address (DISP, 1 km grid)

10 (6, 13)

NA

8 (4, 13)

[38]

M.I. registry studies

       

Stockholm

NO2

14 (3 – 32)

Address (DISP)

NA

15 (−1, 33)

NA

[72]

Rome residents

NO2

(<30 - > 60)

Census block (LUR)

NA

7 (2, 12)

NA

[73]

Stockholm residents

NO2

12 (2 – 33)

Address (DISP)

NA

8 (5, 11)

NA

[74]

IHD = ischemic heart disease; MI = myocardial infarction. Fatal MI reported for registry studies. NA = not available.

a Mean with minimum – maximum in parentheses (μg/m3). One number in parentheses is standard deviation.

b Spatial scale of exposure assignment, in parentheses exposure assignment method. City = average of monitors within the city; Near = nearest monitor concentration; LUR = land use regression; Disp = dispersion modeling; Inter = interpolation.

c Median and 90th percentile reported.

Studies adjusted for individual smoking except references [26, 28, 30, 34, 38, 56].

Fewer studies have evaluated cerebrovascular mortality. In the Dutch cohort study and in the Women’s Health Initiative Study, a strong association was found [22, 23]. In contrast, in the ACS study, the Norwegian cohort, and the Swiss national cohort study no association was found [28, 39, 68]. It is possible that poorer recording of cerebrovascular mortality on death certificates has contributed to these inconsistencies. There is also some evidence from ecological studies that air pollution may contribute to stroke mortality [78, 79].

Two studies have reported significant associations between particulate matter air pollution and dysrhythmia, heart failure and cardiac arrest combined [39, 60]. These results are based upon smaller numbers of events, and require large cohort studies for further verification. The results are consistent with several studies documenting significant associations between short-term PM or NO2 exposure and mortality due to heart failure and dysrhythmia and defibrillator discharges [4, 80].

Air pollution and respiratory mortality

Table 6 shows the effect estimates for respiratory mortality. In the two first US cohort studies, no association between PM2.5 and respiratory mortality was found [15, 17]. In contrast to the findings of these US studies, strong associations were found in the Dutch cohort study [23], a Norwegian study [68] and a Chinese study [59]. The random effect pooled estimate per 10 μg/m3 for PM2.5 was 2.9% (95%CI −5.9, 12.6%), highly non-significant. The heterogeneity across studies was statistically significant with an I2 statistic of 59%, indicating moderate heterogeneity. Associations for PM were weaker in the Dutch and Chinese cohort study than with NO2 or NOx. Respiratory mortality may be more related to primary traffic-related pollutants than with long-range transported particles, though further work is needed to test this hypothesis. The smaller number of deaths due to respiratory disease compared to cardiovascular diseases, contributed to larger confidence intervals within individual studies and larger variability of the main effect estimates across studies. In time series studies including several large multi-city studies in the USA and Europe, significant associations between daily variations in PM and respiratory mortality were found [14]. Expressed per 10 μg/m3 PM excess risks of about 1% are typically reported for short-term exposures, larger than for all-cause mortality [14]. In contrast to cardiovascular disease, current evidence therefore does not suggest an additional risk from long-term exposure, possibly related to mortality displacement [2, 3]. More studies are needed to evaluate long-term exposures on respiratory mortality more thoroughly.
Table 6

Summary of the studies on air pollution and mortality from all respiratory disease (excess risk per 10 μg/m 3 )

Study Name

Pollutant

Conca(μg/m3)

Spatial scaleb

% change in risk (95% CI) in mortality per 10 μg/m3

References

AHSMOG

PM10

51 (17)

Address (Inter)

6 (−1, 15)

[40]

ACS study

PM2.5

17 (5)

City

−8 (−14, -2)

[39]

Oslo cohort

NOx

11 (1 – 168)

Address (DISP)

16 (6, 26)

[68]

Harvard six cities

PM2.5

15 (10–22)

City

8 (−21, 49)

[14]

Netherlands Cohort Study

PM2.5

28 (23–37)

Address (LUR)

7 (−25, 52)

[23]

Netherlands Cohort Study

NO2

37 (15–67)

Address (LUR)

12 (0, 26)

[23]

California Teachers study

PM2.5

18 (7–39)

Address (near)

3 (−20, 34)

[27]

China national. hypertension survey

NOx

50 (20 – 122)

City

3 (0, 6)

[31]

China national. hypertension survey

TSP

289 (113 – 499)

City

0.3 (−1,1)

[31]

US truckers study

PM2.5

14 (4)

Address (near)

20 (−9, 60)

[32]

US truckers study

NO2

28 (14)

Address (LUR)

15 (1,31)

[32]

California Teachers study

PM2.5

16 (3–28)

Address (Inter)

21 (−3, 52)

[36]

New Zealand Census study

PM10

8 (0 – 19)

Census tract (Disp)

14 (5, 23)

[35]

Shenyang cohort study

PM10

154 (78 – 274)

District (mean)

67 (60, 74)

[59]

Shenyang cohort study

NO2

46 (18–78)

District (mean)

197 (169, 227)

[59]

Shizuoka elderly cohort

NO2

25 (−19, 75)

Address (LUR)

19 (2, 38)

[70]

Two Scotch cohorts

BS

19

LUR + temporal

11 (−3, 28)

[67]

Rome longitudinal study

PM2.5

23 (7 – 32)

Address (DISP, 1 km grid)

3 (−3, 8)

[38]

a Mean with minimum – maximum in parentheses (μg/m3). One number in parentheses is standard deviation.

b Spatial scale of exposure assignment, in parentheses exposure assignment method. City = average of monitors within the city; Near = nearest monitor concentration; LUR = land use regression; Disp = dispersion modeling; Inter = interpolation.

Studies adjusted for individual smoking except references [26, 28, 30, 34, 38, 56].

Conclusions

There is a significant number of new studies on long-term air pollution exposure, covering a wider geographic area, including Asia. These recent studies support associations found in previous cohort studies on PM2.5. The pooled effect estimate expressed as excess risk per 10 μg/m3 increase in PM2.5 exposure was 6% (95% CI 4, 8%) for all-cause and 11% (95% 5, 16%) for cardiovascular mortality. Long-term exposure to PM2.5 was more associated with mortality from cardiovascular disease (particularly ischemic heart disease) than from non-malignant respiratory diseases (pooled estimate 3% (95% CI −6, 13%)). Significant heterogeneity in PM2.5 effect estimates was found across studies, likely related to differences in particle composition, infiltration of particles indoors, population characteristics and methodological differences in exposure assessment and confounder control. All-cause mortality was significantly associated with elemental carbon (pooled estimate per 1 μg/m3 6% (95% CI 5, 7%)) and NO2 (pooled estimate per 10 μg/m3 5% (95% CI 3, 8%)), both markers of combustion sources. There was little evidence for an association between long term coarse particulate matter exposure and mortality, possibly due to the small number of studies and limitations in exposure assessment. Across studies, there was little evidence for stronger association among women compared to men. Subjects with lower education and obese subjects experienced larger mortality effect related to fine PM, though the evidence for differences related to education has been weakened in more recent studies.

Our review suggests several specific research questions. Research into the reasons for the heterogeneity of effect estimates would be extremely useful for health impact assessment. Better exposure assessment including spatially resolved outdoor exposures and more chemically speciated PM might in part be able to resolve the observed heterogeneity. Chemical speciation would allow assessing particles from different sources e.g. particles from combustion sources and non-tailpipe emissions separately, a question clearly relevant for air pollution control policy. Specific attention to motorized traffic emissions is important because (road) traffic is an important source of ambient air pollution. More work on coarse particles and at the other side of the particle size spectrum, ultrafine particles is needed. Ongoing new research in the USA in the Multi-Ethnic study of Atherosclerosis and Air pollution (MESA-AIR) and the European Study of Cohorts for Air Pollution Effects (ESCAPE) that use large cohorts and state-of the art spatially-resolved exposure methods will likely contribute significant new answers in the near future to these questions.

Abbreviations

ACS: 

American Cancer Society study

BS: 

Black Smoke

BC: 

Black Carbon

CI: 

Confidence interval

EC: 

Elemental Carbon

NO2: 

Nitrogen dioxide

NOx: 

Nitrogen oxides

PM: 

Particulate matter

PM2.5: 

Particles smaller than 2.5 μm

PM10: 

Particles smaller than 10 μm

TSP: 

Total suspended particles.

Declarations

Acknowledgments

The paper has been prepared in the framework of the projects ESCAPE and TRANSPHORM. The research leading to these results has received funding from the European Community’s Seventh Framework Program (FP7/2007-2011) under grant agreement number: 211250.

Authors’ Affiliations

(1)
Institute of Risk Assessment Sciences, University of Utrecht
(2)
University of Washington
(3)
Institute of Epidemiology II, Helmholtz Zentrum München –German Research Center for Environmental Health
(4)
Air Pollution Epidemiology Section, Office of Environmental Health Hazard Assessment, State of California
(5)
Julius Center for Health Sciences and Primary Care, University Medical Center

References

  1. World Health Organization: Systematic review of air pollution, a global update. 2006
  2. Pope CA, Dockery DW: Health effects of fine particulate air pollution: lines that connect. J Air Waste Manag Assoc. 2006, 56: 709-742. 10.1080/10473289.2006.10464485.View Article
  3. Brunekreef B, Holgate ST: Air pollution and health. Lancet. 2002, 360: 1233-1242. 10.1016/S0140-6736(02)11274-8.View Article
  4. Brook RD, Rajagopalan S, Pope CA, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC, Whitsel L, Kaufman JD: Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American heart association. Circulation. 2010, 121: 2331-2378. 10.1161/CIR.0b013e3181dbece1.View Article
  5. Krishnan RM, Kaufman JD, Hoek G: Chronic effects of air pollution on cardiovascular health. Cardiovascular effects of inhaled ultrafine and nanosized particles. Edited by: Cassee FR, Mills NL, Newby D. 2011, Hoboken, New Jersey: John Wiley & Sons, Inc
  6. HEI panel: HEI Special report 17. Traffic-related air pollution. A critical review of the literature on emissions, exposure and health effects. 2010, Boston, MA: Health Effects Institute
  7. Janssen NA, Hoek G, Simic-Lawson M, Fischer P, van Bree L, ten Brink H, Keuken M, Atkinson RW, Anderson HR, Brunekreef B, Cassee FR: Black carbon as an additional indicator of the adverse effects of airborne particles compared with PM10 and PM2.5. Environ Health Perspect. 2011, 119: 1691-1699. 10.1289/ehp.1003369.View Article
  8. Peters A, Rückerl R, Cyrys J: Lessons from air pollution epidemiology for studies of engineered nanomaterials. J Occup Environ Med. 2011, 53 (6 SUPPL): S8-S13.View Article
  9. Rückerl R, Schneider A, Breitner S, Cyrys J, Peters A: Health effects of particulate air pollution: a review of epidemiological evidence. Inhal Toxicol. 2011, 23: 555-592. 10.3109/08958378.2011.593587.View Article
  10. Boogaard H, Kos GPA, Weijers EP, Janssen NAH, Fischer PH, van der Zee SC, de Hartog JJ, Hoek G: Contrast in air pollution components between major streets and background locations: particulate matter mass, black carbon, elemental composition, nitrogen oxide and ultrafine particle number. Atmos Environ. 2011, 45: 650-658. 10.1016/j.atmosenv.2010.10.033.View Article
  11. Brunekreef B, Forsberg B: Epidemiological evidence of effects of coarse airborne particles on health. Eur Respir J. 2005, 26: 309-318. 10.1183/09031936.05.00001805.View Article
  12. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 177, 7: 177-188.View Article
  13. Higgins JPT, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. Br Med J. 2003, 327: 557-560. 10.1136/bmj.327.7414.557.View Article
  14. Laden F, Schwartz J, Speizer FE, Dockery DW: Reduction in fine particulate Air pollution and mortality: extended follow-up of the Harvard Six cities study. Am J Respir Crit Care Med. 2006, 173: 667-672. 10.1164/rccm.200503-443OC.View Article
  15. Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Speizer FE: An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993, 329: 1753-1759. 10.1056/NEJM199312093292401.View Article
  16. Lepeule J, Laden F, Dockery D, Schwartz J: Chronic exposure to fine particles and mortality: an extended follow-up of the Harvard six cities study from 1974 to 2009. Environ Health Perspect. 2012, 120: 965-970. 10.1289/ehp.1104660.View Article
  17. Pope CA, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, Jr HC: Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med. 1995, 151: 669-674. 10.1164/ajrccm/151.3_Pt_1.669.View Article
  18. Pope CA, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD: Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002, 287: 1132-1141. 10.1001/jama.287.9.1132.View Article
  19. Jerrett M, Burnett RT, Ma R, Pope CA, Krewski D, Newbold KB, Thurston G, Shi Y, Finkelstein N, Calle EE, Thun MJ: Spatial analysis of air pollution and mortality in Los Angeles. Epidemiology. 2005, 16: 727-736. 10.1097/01.ede.0000181630.15826.7d.View Article
  20. Gehring U, Heinrich J, Kramer U, Grote V, Hochadel M, Sugiri D, Kraft M, Rauchfuss K, Eberwein HG, Wichmann HE: Long-term exposure to ambient air pollution and cardiopulmonary mortality in women. Epidemiology. 2006, 17: 545-551. 10.1097/01.ede.0000224541.38258.87.View Article
  21. Heinrich J, Thiering E, Rzehak P, Krämer U, Hochadel M, Rauchfuss KM, Gehring U, Wichmann H: Long-term exposure to NO2 and PM10 and all-cause and cause-specific mortality in a prospective cohort of women. Occup Environ Med. 2013, 70: 179-186. 10.1136/oemed-2012-100876.View Article
  22. Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman JD: Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007, 356: 447-458. 10.1056/NEJMoa054409.View Article
  23. Beelen R, Hoek G, van den Brandt PA, Goldbohm RA, Fischer P, Schouten LJ, Jerrett M, Hughes E, Armstrong B, Brunekreef B: Long-term effects of traffic-related air pollution on mortality in a Dutch cohort (NLCS-AIR study). Environ Health Perspect. 2008, 116: 196-202. 10.1289/ehp.10614.View Article
  24. Puett RC, Schwartz J, Hart JE, Yanosky JD, Speizer FE, Suh H, Paciorek CJ, Neas LM, Laden F: Chronic particulate exposure, mortality, and coronary heart disease in the Nurses’ Health Study. Am J Epidemiol. 2008, 168: 1161-1168. 10.1093/aje/kwn232.View Article
  25. Puett RC, Hart JE, Yanosky JD, Paciorek C, Schwartz J, Suh H, Speizer FE, Laden F: Chronic fine and coarse particulate exposure, mortality, and coronary heart disease in the Nurses’ Health Study. Environ Health Perspect. 2009, 117: 1697-1701. 10.1289/ehp.0900572.View Article
  26. Zeger SL, Dominici F, McDermott A, Samet JM: Mortality in the Medicare population and chronic exposure to fine particulate air pollution in urban centers (2000–2005). Environ Health Perspect. 2008, 116: 1614-1619. 10.1289/ehp.11449.View Article
  27. Ostro B, Lipsett M, Reynolds P, Goldberg D, Hertz A, Garcia C, Henderson KD, Bernstein L: Long-term exposure to constituents of fine particulate air pollution and mortality: results from the California teachers study. Environ Health Perspect. 2010, 118: 363-369.View Article
  28. Huss A, Spoerri A, Egger M, Röösli M: Aircraft noise, air pollution, and mortality from myocardial infarction. Epidemiology. 2010, 21: 829-836. 10.1097/EDE.0b013e3181f4e634.View Article
  29. Puett RC, Hart JE, Suh H, Mittleman M, Laden F: Particulate matter exposures, mortality, and cardiovascular disease in the health professionals follow-up study. Environ Health Perspect. 2011, 119: 1130-1135. 10.1289/ehp.1002921.View Article
  30. Gan WQ, Koehoorn M, Davies HW, Demers PA, Tamburic L, Brauer M: Long-term exposure to traffic-related air pollution and the risk of coronary heart disease hospitalization and mortality. Environ Health Perspect. 2011, 119: 501-507.View Article
  31. Cao J, Yang C, Li J, Chen R, Chen B, Gu D, Kan H: Association between long-term exposure to outdoor air pollution and mortality in China: a cohort study. J Hazard Mater. 2011, 186: 1594-1600. 10.1016/j.jhazmat.2010.12.036.View Article
  32. Hart JE, Garshick E, Dockery DW, Smith TJ, Ryan L, Laden F: Long-term ambient multipollutant exposures and mortality. Am J Respir Crit Care Med. 2011, 183: 73-78. 10.1164/rccm.200912-1903OC.View Article
  33. Zhang P, Dong G, Sun B, Zhang L, Chen X, Ma N, Yu F, Guo H, Huang H, Lee YL, Tang N, Chen J: Long-term exposure to ambient air pollution and mortality due to cardiovascular disease and cerebrovascular disease in Shenyang, China. PLoS One. 2011, 6: e20827-10.1371/journal.pone.0020827.View Article
  34. Crouse DL, Peters PA, van Donkelaar A, Goldberg MS, Villeneuve PJ, Brion O, Khan S, Atari DO, Jerrett M, Pope CA, Brauer M, Brook JR, Martin RV, Stieb D, Burnett RT: Risk of nonaccidental and cardiovascular mortality in relation to long-term exposure to low concentrations of fine particulate matter: a Canadian national-level cohort study. Environ Health Perspect. 2012, 120: 708-714. 10.1289/ehp.1104049.View Article
  35. Hales S, Blakely T, Woodward A: Air pollution and mortality in New Zealand: cohort study. J Epidemiol Community Health. 2012, 66: 468-473. 10.1136/jech.2010.112490.View Article
  36. Lipsett MJ, Ostro BD, Reynolds P, Goldberg D, Hertz A, Jerrett M, Smith DF, Garcia C, Chang ET, Bernstein L: Long-term exposure to air pollution and cardiorespiratory disease in the California teachers study cohort. Am J Respir Crit Care Med. 2011, 184: 828-835. 10.1164/rccm.201012-2082OC.View Article
  37. Ueda K, Nagasawa SY, Nitta H, Miura K, Ueshima H, NIPPON DATA80 Research Group: Exposure to particulate matter and long-term risk of cardiovascular mortality in Japan: NIPPON DATA80. J Atheroscler Thromb. 2012, 19: 246-254. 10.5551/jat.9506.View Article
  38. Cesaroni G, Badaloni C, Gariazzo C, Stafoggia M, Sozzi R, Davoli M, Forastiere F: Long-term exposure to urban air pollution and mortality in a cohort of more than a million adults in Rome. Environ Health Perspect. 2013, 121: 324-331. 10.1289/ehp.1205862.View Article
  39. Pope CA, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ: Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004, 109: 71-77.View Article
  40. Abbey DE, Nishino N, McDonnell WF, Burchette RJ, Knutsen SF, Lawrence BW, Yang JX: Long-term inhalable particles and other air pollutants related to mortality in nonsmokers. Am J Respir Crit Care Med. 1999, 159: 373-382. 10.1164/ajrccm.159.2.9806020.View Article
  41. Chen LH, Knutsen SF, Shavlik D, Beeson WL, Petersen F, Ghamsary M, Abbey D: The association between fatal coronary heart disease and ambient particulate air pollution: Are females at greater risk?. Environ Health Perspect. 2005, 113: 1723-1729. 10.1289/ehp.8190.View Article
  42. Filleul L, Rondeau V, Vandentorren S, Le Moual N, Cantagrel A, Annesi-Maesano I, Charpin D, Declercq C, Neukirch F, Paris C, Vervloet D, Brochard P, Tessier JF, Kauffmann F, Baldi I: Twenty five year mortality and air pollution: results from the French PAARC survey. Occup Environ Med. 2005, 62: 453-460. 10.1136/oem.2004.014746.View Article
  43. Krewski D, Jerrett M, Burnett RT, Ma R, Hughes E, Shi Y, Turner MC, Pope CA, Thurston G, Calle EE, Thun MJ, Beckerman B, DeLuca P, Finkelstein N, Ito K, Moore DK, Newbold KB, Ramsay T, Ross Z, Shin H, Tempalski B: Extended follow-up and spatial analysis of the American cancer society study linking particulate air pollution and mortality. Res Rep Health Eff Inst. 2009, 140: 5-114. discussion 115–36
  44. Ljungman P, Bellander T, Schneider A, Breitner S, Forastiera F, Hampel R, Illig T, Jacquemin B, Katsouyanni K, von Klot S, Koenig W, Lanki T, Nyberg F, Pekkanen J, Pistelli R, Pitsavos C, Rosenqvist M, Sunyer J, Peters A: Modification of the interleukin-6 response to air pollution by interleukin-6 and fibrinogen polymorphisms. Environ Health Perspect. 2009, 117: 1373-1379.View Article
  45. Peters A, Greven S, Heid IM, Baldari F, Breitner S, Bellander T, Chrysohoou C, Illig T, Jacquemin B, Koenig W, Lanki T, Nyberg F, Pekkanen J, Pistelli R, Rückerl R, Stefanadis C, Schneider A, Sunyer J, Wichmann HE: Fibrinogen genes modify the fibrinogen response to ambient particulate matter. Am J Respir Crit Care Med. 2009, 179: 484-491. 10.1164/rccm.200805-751OC.View Article
  46. Janssen NA, Schwartz J, Zanobetti A, Suh HH: Air conditioning and source-specific particles as modifiers of the effect of PM(10) on hospital admissions for heart and lung disease. Environ Health Perspect. 2002, 110: 43-49. 10.1289/ehp.02110s143.View Article
  47. Mercer LD, Szpiro AA, Sheppard L, Lindström J, Adar SD, Allen RW, Avol EL, Oron AP, Larson T, Liu L-S, Kaufman JD: Comparing universal kriging and land-use regression for predicting concentrations of gaseous oxides of nitrogen (NOx) for the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air). Atmos Environ. 2011, 45: 4412-4420. 10.1016/j.atmosenv.2011.05.043.View Article
  48. Cohen MA, Adar SD, Allen RW, Avol E, Curl CL, Gould T, Hardie D, Ho A, Kinney P, Larson TV, Sampson P, Sheppard L, Stukovsky KD, Swan SS, Liu L-S, Kaufman JD: Approach to estimating participant pollutant exposures in the Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air). Environ Sci Technol. 2009, 43: 4687-4693. 10.1021/es8030837.View Article
  49. Van Roosbroeck S, Hoek G, Meliefste K, Janssen NA, Brunekreef B: Validity of residential traffic intensity as an estimate of long-term personal exposure to traffic-related air pollution among adults. Environ Sci Technol. 2008, 42: 1337-1344. 10.1021/es0712827.View Article
  50. Katsouyanni K, Touloumi G, Samoli E, Gryparis A, Le Tertre A, Monopolis Y, Rossi G, Zmirou D, Ballester F, Boumghar A, Anderson HR, Wojtyniak B, Paldy A, Braunstein R, Pekkanen J, Schindler C, Schwartz J: Confounding and effect modification in the short-term effects of ambient particles on total mortality: results from 29 European cities within the APHEA2 project. Epidemiology. 2001, 12: 521-531. 10.1097/00001648-200109000-00011.View Article
  51. Laden F, Neas LM, Dockery DW, Schwartz J: Association of fine particulate matter from different sources with daily mortality in six U.S. cities. Environ Health Perspect. 2000, 108: 941-947. 10.1289/ehp.00108941.View Article
  52. Lanki T, de Hartog JJ, Heinrich J, Hoek G, Janssen NA, Peters A, Stolzel M, Timonen KL, Vallius M, Vanninen E, Pekkanen J: Can we identify sources of fine particles responsible for exercise-induced ischemia on days with elevated air pollution? The ULTRA study. Environ Health Perspect. 2006, 114: 655-660. 10.1289/ehp.8578.View Article
  53. Bell ML, Ebisu K, Peng RD, Samet JM, Dominici F: Hospital admissions and chemical composition of fine particle air pollution. Am J Respir Crit Care Med. 2009, 179: 1115-1120. 10.1164/rccm.200808-1240OC.View Article
  54. Zanobetti A, Bind MA, Schwartz J: Particulate air pollution and survival in a COPD cohort. Environ Health. 2008, 7: 48-10.1186/1476-069X-7-48.View Article
  55. Zanobetti A, Schwartz J: Particulate air pollution, progression, and survival after myocardial infarction. Environ Health Perspect. 2007, 115: 769-775. 10.1289/ehp.9201.View Article
  56. Cesaroni G, Porta D, Badaloni C, Stafoggia M, Eeftens M, Meliefste K, Forastiere F: Nitrogen dioxide levels estimated from land use regression models several years apart and association with mortality in a large cohort study. Environ Health. 2012, 11: 48-10.1186/1476-069X-11-48.View Article
  57. Eeftens M, Beelen R, Fischer P, Brunekreef B, Meliefste K, Hoek G: Stability of measured and modelled spatial contrasts in NO2 over time. Occup Environ Med. 2011, 68: 765-770. 10.1136/oem.2010.061135.View Article
  58. Wang R, Henderson SB, Sbihi H, Allen RW, Brauer M: Temporal stability of land use regression models for traffic-related air pollution. Atmos Environ. 2013, 64: 312-319.View Article
  59. Dong GH, Zhang P, Sun B, Zhang L, Chen X, Ma N, Yu F, Guo H, Huang H, Lee YL, Tang N, Chen J: Long-term exposure to ambient air pollution and respiratory disease mortality in Shenyang, China: a 12-year population-based retrospective cohort study. Respiration. 2012, 84: 360-368. 10.1159/000332930.View Article
  60. Beelen R, Hoek G, Houthuijs D, van den Brandt PA, Goldbohm RA, Fischer P, Schouten LJ, Armstrong B, Brunekreef B: The joint association of air pollution and noise from road traffic with cardiovascular mortality in a cohort study. Occup Environ Med. 2009, 66: 243-250.View Article
  61. Selander J, Nilsson ME, Bluhm G, Rosenlund M, Lindqvist M, Nise G, Pershagen G: Long-term exposure to road traffic noise and myocardial infarction. Epidemiology. 2009, 20: 272-279. 10.1097/EDE.0b013e31819463bd.View Article
  62. Gan WQ, Davies HW, Koehoorn M, Brauer M: Association of long-term exposure to community noise and traffic-related air pollution with coronary heart disease mortality. Am J Epidemiol. 2012, 175: 898-906. 10.1093/aje/kwr424.View Article
  63. McDonnell WF, Nishino-Ishikawa N, Petersen FF, Chen LH, Abbey DE: Relationships of mortality with the fine and coarse fractions of long-term ambient PM10 concentrations in nonsmokers. J Expo Anal Environ Epidemiol. 2000, 10: 427-436. 10.1038/sj.jea.7500095.View Article
  64. Smith KR, Jerrett M, Anderson HR, Burnett RT, Stone V, Derwent R, Atkinson RW, Cohen A, Shonkoff SB, Krewski D, Pope CA, Thun MJ, Thurston G: Public health benefits of strategies to reduce greenhouse-gas emissions: health implications of short-lived greenhouse pollutants. Lancet. 2009, 374: 2091-2103. 10.1016/S0140-6736(09)61716-5.View Article
  65. von Klot S, Gryparis A, Tonne C, Yanosky J, Coull BA, Goldberg RJ, Lessard D, Melly SJ, Suh HH, Schwartz J: Elemental carbon exposure at residence and survival after acute myocardial infarction. Epidemiology. 2009, 20: 547-554. 10.1097/EDE.0b013e31819d9501.View Article
  66. Lipfert F, Wyzga R, Baty J, Miller J: Traffic density as a surrogate measure of environmental exposures in studies of air pollution health effects: long-term mortality in a cohort of US veterans. Atmos Environ. 2006, 40: 154-169. 10.1016/j.atmosenv.2005.09.027.View Article
  67. Beverland IJ, Cohen GR, Heal MR, Carder M, Yap C, Robertson C, Hart CL, Agius RM: A comparison of short-term and long-term air pollution exposure associations with mortality in two cohorts in Scotland. Environ Health Perspect. 2012, 120: 1280-1285. 10.1289/ehp.1104509.View Article
  68. Nafstad P, Haheim LL, Wisloff T, Gram F, Oftedal B, Holme I, Hjermann I, Leren P: Urban air pollution and mortality in a cohort of Norwegian men. Environ Health Perspect. 2004, 112: 610-615. 10.1289/ehp.6684.View Article
  69. Raaschou-Nielsen O, Andersen ZJ, Jensen SS, Ketzel M, Sorensen M, Hansen J, Loft S, Tjonneland A, Overvad K: Traffic air pollution and mortality from cardiovascular disease and all causes: a Danish cohort study. Environ Health. 2012, 11: 60-10.1186/1476-069X-11-60.View Article
  70. Yorifuji T, Kashima S, Tsuda T, Takao S, Suzuki E, Doi H, Sugiyama M, Ishikawa-Takata K, Ohta T: Long-term exposure to traffic-related air pollution and mortality in Shizuoka, Japan. Occup Environ Med. 2010, 67: 111-117. 10.1136/oem.2008.045542.View Article
  71. Chen H, Goldberg MS, Burnett RT, Jerrett M, Wheeler AJ, Villeneuve PJ: Long-term exposure to traffic-related air pollution and cardiovascular mortality. Epidemiology. 2013, 24: 35-43. 10.1097/EDE.0b013e318276c005.View Article
  72. Rosenlund M, Berglind N, Pershagen G, Hallqvist J, Jonson T, Bellander T: Long-term exposure to urban air pollution and myocardial infarction. Epidemiology. 2006, 17: 383-390. 10.1097/01.ede.0000219722.25569.0f.View Article
  73. Rosenlund M, Picciotto S, Forastiere F, Stafoggia M, Perucci CA: Traffic-related air pollution in relation to incidence and prognosis of coronary heart disease. Epidemiology. 2008, 19: 121-128. 10.1097/EDE.0b013e31815c1921.View Article
  74. Rosenlund M, Bellander T, Nordquist T, Alfredsson L: Traffic-generated air pollution and myocardial infarction. Epidemiology. 2009, 20: 265-271. 10.1097/EDE.0b013e318190ea68.View Article
  75. Heckbert SR, Kooperberg C, Safford MM, Psaty BM, Hsia J, McTiernan A, Gaziano JM, Frishman WH, Curb JD: Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women’s Health Initiative. Am J Epidemiol. 2004, 160: 1152-1158. 10.1093/aje/kwh314.View Article
  76. Mills NL, Donaldson K, Hadoke PW, Boon NA, MacNee W, Cassee FR, Sandstrom T, Blomberg A, Newby DE: Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med. 2009, 6: 36-44. 10.1038/ncpcardio1399.View Article
  77. Kunzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, Thomas D, Peters J, Hodis HN: Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect. 2005, 113: 201-206.View Article
  78. Maheswaran R, Elliott P: Stroke mortality associated with living near main roads in England and Wales: a geographical study. Stroke. 2003, 34: 2776-2780. 10.1161/01.STR.0000101750.77547.11.View Article
  79. Maheswaran R, Haining RP, Pearson T, Law J, Brindley P, Best NG: Outdoor NOx and stroke mortality: adjusting for small area level smoking prevalence using a Bayesian approach. Stat Methods Med Res. 2006, 15: 499-516.
  80. Ljungman PL, Berglind N, Holmgren C, Gadler F, Edvardsson N, Pershagen G, Rosenqvist M, Sjögren B, Bellander T: Rapid effects of air pollution on ventricular arrhythmias. Eur Heart J. 2008, 29: 2894-2901. 10.1093/eurheartj/ehn463.View Article

Copyright

© Hoek et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement